Texas Top Legal Officer Sues Acetaminophen Manufacturers Concerning Autism Spectrum Assertions
Texas Attorney General Ken Paxton is suing the makers of Tylenol, alleging the companies hid alleged dangers that the pain reliever presented to pediatric brain development.
The lawsuit arrives four weeks after President Donald Trump publicized an unproven link between consuming acetaminophen - alternatively called acetaminophen - while pregnant and autism in offspring.
The attorney general is taking legal action against J&J, which previously sold the drug, the sole analgesic suggested for women during pregnancy, and the current manufacturer, which now manufacturers it.
In a declaration, he said they "betrayed America by gaining financially from suffering and marketing drugs ignoring the risks."
Kenvue states there is insufficient reliable data linking Tylenol to autism.
"These companies lied for decades, intentionally threatening countless individuals to boost earnings," the attorney general, a Republican, declared.
The manufacturer stated officially that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the welfare of American women and children."
On its website, Kenvue also mentioned it had "continuously evaluated the relevant science and there is insufficient valid information that indicates a proven link between using acetaminophen and autism spectrum disorder."
Groups acting on behalf of doctors and medical practitioners concur.
The American College of Obstetricians and Gynecologists has declared paracetamol - the main ingredient in acetaminophen - is one of the few options for pregnant women to manage discomfort and fever, which can create major wellness concerns if not addressed.
"In over twenty years of studies on the use of paracetamol in pregnancy, no reliable research has successfully concluded that the consumption of acetaminophen in any period of gestation causes neurological conditions in offspring," the organization commented.
This legal action mentions recent announcements from the former administration in asserting the medication is allegedly unsafe.
Recently, the former president raised alarms from medical authorities when he told pregnant women to "struggle intensely" not to consume acetaminophen when ill.
The US Food and Drug Administration then published an announcement that doctors should consider limiting the consumption of Tylenol, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in minors has not been established.
The Health Department head RFK Jr, who manages the Food and Drug Administration, had pledged in spring to undertake "a massive testing and research effort" that would establish the cause of autism spectrum disorder in a short period.
But experts warned that finding a single cause of autism - believed by scientists to be the outcome of a intricate combination of genetic and surrounding conditions - would be difficult.
Autism is a form of permanent neurological difference and impairment that affects how people perceive and interact with the surroundings, and is recognized using doctors' observations.
In his court filing, the attorney general - who supports Trump who is campaigning for federal office - alleges Kenvue and J&J "intentionally overlooked and sought to suppress the evidence" around acetaminophen and autism spectrum disorder.
The lawsuit aims to force the firms "remove any promotional materials" that states acetaminophen is reliable for women during pregnancy.
The Texas lawsuit mirrors the grievances of a assembly of parents of minors with autism and ADHD who filed suit against the producers of Tylenol in two years ago.
The court threw out the lawsuit, saying research from the plaintiffs' authorities was inconclusive.